tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

QURE Stock Latest News

Midday Fly By: Job growth comes in below forecasts in December
The FlyMidday Fly By: Job growth comes in below forecasts in December
2d ago
C
Z
uniQure prepares for FDA Type A meeting on AMT-130
PremiumCompany Announcements
uniQure prepares for FDA Type A meeting on AMT-130
2d ago
8K
QURE
uniQure announces Type A meeting scheduled with FDA
PremiumThe Fly
uniQure announces Type A meeting scheduled with FDA
2d ago
QURE
U.S. Chess Champion is Bullish on these 3 Stocks – In-Demand QURE, Unsexy AMZN and Reliable BRK.
PremiumMarket News
U.S. Chess Champion is Bullish on these 3 Stocks – In-Demand QURE, Unsexy AMZN and Reliable BRK.
6d ago
AMZN
uniQure call volume above normal and directionally bullish
PremiumThe Fly
uniQure call volume above normal and directionally bullish
26d ago
QURE
uniQure price target lowered to $40 from $50 at Stifel
PremiumThe FlyuniQure price target lowered to $40 from $50 at Stifel
1M ago
QURE
uniQure price target lowered to $33 from $60 at Mizuho
Premium
The Fly
uniQure price target lowered to $33 from $60 at Mizuho
1M ago
QURE
These 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025
Premium
Market News
These 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025
1M ago
ABSI
GRPN
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
PremiumThe Fly
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
1M ago
BP
DG
Video: Salesforce rises, Snowflake dips after quarterly reports
PremiumThe Fly
Video: Salesforce rises, Snowflake dips after quarterly reports
1M ago
DG
CRM
uniQure Faces Setback in Gene Therapy Approval
PremiumCompany Announcements
uniQure Faces Setback in Gene Therapy Approval
1M ago
8K
QURE
uniQure says FDA announced Phase I/II AMT-130 data unlikely to support BLA
PremiumThe Fly
uniQure says FDA announced Phase I/II AMT-130 data unlikely to support BLA
1M ago
QURE
uniQure put volume heavy and directionally bearish
PremiumThe FlyuniQure put volume heavy and directionally bearish
2M ago
QURE
Citizens JMP healthcare analysts hold an analyst/industry conference
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
2M ago
BNTC
CRSP
Positive Long-Term Outlook for uniQure Amid Strong Data and Strategic Advancements
Premium
Ratings
Positive Long-Term Outlook for uniQure Amid Strong Data and Strategic Advancements
2M ago
QURE
uniQure Reports Q3 2025 Results and Clinical Progress
PremiumCompany Announcements
uniQure Reports Q3 2025 Results and Clinical Progress
2M ago
QURE
uniQure N.V. Earnings Call: Pipeline Progress Amid Challenges
PremiumCompany Announcements
uniQure N.V. Earnings Call: Pipeline Progress Amid Challenges
2M ago
QURE
uniQure’s AMT-130: Promising Results Amid Regulatory Challenges Support Buy Rating
PremiumRatings
uniQure’s AMT-130: Promising Results Amid Regulatory Challenges Support Buy Rating
2M ago
QURE
uniQure’s AMT-130: A Promising Breakthrough in Huntington’s Disease Treatment Amidst Regulatory Challenges
PremiumRatings
uniQure’s AMT-130: A Promising Breakthrough in Huntington’s Disease Treatment Amidst Regulatory Challenges
2M ago
QURE
uniQure price target lowered to $60 from $68 at Leerink
PremiumThe FlyuniQure price target lowered to $60 from $68 at Leerink
2M ago
QURE
uniQure’s Regulatory Challenges and Mixed Signals Lead to Hold Rating
Premium
Ratings
uniQure’s Regulatory Challenges and Mixed Signals Lead to Hold Rating
2M ago
QURE
uniQure reports Q3 EPS ($1.38), consensus (76c)
Premium
The Fly
uniQure reports Q3 EPS ($1.38), consensus (76c)
2M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >